Concentra Group Holdings Parent — Earnings Quality Grade F
CON · Healthcare
Major red flags
Screening Summary
Management Signals
Financial Trends
Revenue & Net Income ($B)
Margins (%)
18-Point Screening
Revenue Quality
DSO 44 days, change +2 days YoY
AR growth 18.5% vs revenue growth 13.9%
Revenue grew 13.9% but CFFO only 1.7%
Expense Quality
No material inventory
CapEx growth 28.0% is >2x revenue growth 13.9%
SG&A/Gross Profit = 33.2%. Normal
Gross margin 28.3%, change +0.6pp. Stable
Cash Flow Quality
CFFO/NI = 1.68. Profits backed by cash
FCF $0.2B, FCF/NI = 1.18
Accruals ratio = -4.0%. Low accruals
Cash $0.1B covers only 4% of debt $2.1B
Balance Sheet Health
Goodwill+Intangibles $1.7B = 438% of equity. Over 50%
Debt/EBITDA = 5.1x (>4x). Financial stress
Other assets grew 210.6% vs revenue 13.9%
No write-off data
Acquisition Risk
FCF after acquisitions positive
Goodwill+Intangibles change 20% YoY. Normal
Manipulation Score
M-Score = -2.49 (< -2.22). Unlikely manipulator
Portfolio monitoring
Monitor CON continuously
The full checks and model details are free to read. Use Watchlist to track your holdings; Pro adds automatic quarterly rescoring, risk-event email alerts, scans up to 50 tickers, and export workflows.
Beneish M-Score
Altman Z-Score
Generated from public financial data using forensic accounting frameworks. Not investment advice. Data: Yahoo Finance · 2026-04-25